Related references
Note: Only part of the references are listed.Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
Carlo Aschele et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging-Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study
Miguel Nogue et al.
ONCOLOGIST (2011)
Preoperative Oxaliplatin, Capecitabine, and External Beam Radiotherapy in Patients with Newly Diagnosed Primary Operable, cT3NxMo, Low Rectal Cancer A Phase II Study
Dietmar Oefner et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2011)
PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
Christopher H. Crane et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pathological complete response: still a relevant endpoint in rectal cancer?
Yu Jo Chua
LANCET ONCOLOGY (2010)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer
Vaneja Velenik et al.
RADIATION ONCOLOGY (2010)
Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer
Juergen Dunst et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2008)
Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
M. W. Saif et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer
I. Craven et al.
BRITISH JOURNAL OF CANCER (2007)
A phase II study of Preoperative capecitabine and radiation therapy in patients with rectal cancer
Sameer P. Desai et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results
Brian G. Czito et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
F. Willeke et al.
BRITISH JOURNAL OF CANCER (2007)
Comparison of 5-fluorouracilaleucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer
Dae Yong Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Preoperative treatment combining capecitabine with radiation therapy in rectal cancer: A GERCOR phase II study
Olivier Dupuis et al.
ONCOLOGY (2007)
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer
Matilde Navarro et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer:: results from a phase I/II study
G Klautke et al.
BRITISH JOURNAL OF CANCER (2006)
The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
R Glynne-Jones et al.
ANNALS OF ONCOLOGY (2006)
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012
M Mohiuddin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer
C Rödel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients
CG Willett et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer
JC Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921
JF Bosset et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Capecitabine as adjuvant treatment for stage III colon cancer
C Twelves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials
E Van Cutsem et al.
BRITISH JOURNAL OF CANCER (2004)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer
O Glehen et al.
BRITISH JOURNAL OF SURGERY (2003)
First-line oral capecitabine therapy in metastatic colorectal cancer:: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
J Cassidy et al.
ANNALS OF ONCOLOGY (2002)
Preoperative radiotherapy for resectable rectal cancer -: A meta-analysis
C Cammà et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)